Although NF-κB pathway activation plays an important role in host defense, we postulated that short-term NF-κB inhibition initiated after the onset of sepsis-induced inflammation would limit downstream organ injury without impairing host defense against bacterial infection. This evidence concerns the gene NFKB1 and bacterial infectious disease.